Gradient Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Gradient Investments’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$79	–	1937
2023 Q2	$79	Buy	+2	New	+$71	﹤0.01%	1696

Gradient Investments's ISEE Position: Q3 2023 in Review

Gradient Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 2 shares — an estimated $79 sold.

Gradient Investments first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $79 in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Gradient Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Gradient Investments sold 2 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $79.
Gradient Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Gradient Investments's IVERIC bio, Inc. Common Stock position peaked at $79 in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Gradient Investments's 13F filing for Q3 2023, filed 27 Oct 2023.